Wedge Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-15,299
Closed -$168K 567
2020
Q3
$168K Hold
15,299
﹤0.01% 507
2020
Q2
$101K Hold
15,299
﹤0.01% 505
2020
Q1
$94K Buy
15,299
+2,524
+20% +$20.5K ﹤0.01% 501
2019
Q4
$99K Sell
12,775
-90,370
-88% -$624K ﹤0.01% 558
2019
Q3
$611K Hold
103,145
0.01% 384
2019
Q2
$735K Buy
+103,145
New +$468K 0.01% 386

Other funds holding ASPN

Wedge Capital Management's ASPN Position: Q4 2020 in Review

Wedge Capital Management sold out of Aspen Aerogels (ASPN) in Q4 2020, closing a stake of 15,299 shares — an estimated $168K sold.

Wedge Capital Management first reported a position in ASPN in Q2 2019 and held it in 6 quarters. The position peaked at $735K in Q2 2019. 76 funds tracked by Wall St. Rank hold ASPN as of Q4 2020.

  • Wedge Capital Management reported no remaining Aspen Aerogels position as of Q4 2020 after selling out during the quarter.
  • Wedge Capital Management sold 15,299 Aspen Aerogels shares in Q4 2020, an estimated $168K.
  • Wedge Capital Management first reported a position in Aspen Aerogels in Q2 2019 and held it in 6 quarters.
  • Wedge Capital Management's Aspen Aerogels position peaked at $735K in Q2 2019.
  • 76 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2020.

Based on Wedge Capital Management's 13F filing for Q4 2020, filed 8 Jan 2021.